Please login to the form below

Ovarian canncer

This page shows the latest Ovarian canncer news and features for those working in and with pharma, biotech and healthcare.

Another NICE no for AZ’s new ovarian cancer drug

Cost watchdog wants more information for Lynparza. . NICE is once again saying no to AstraZeneca's new ovarian cancer drug - but is opening up a second consultation on its decision. ... The Institute is minded, in preliminary draft guidance, to reject

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Manager / Account Director: Competative

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Senior Medical Writer: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Business Director: Competitive Salary Offered

Account Director – Health Policy – Global Agency: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director: Competitive Salary Offered

Global Business Development Director – Health Education: excellent commission

Senior Account Director development role to Business Director, H...: Excellent package

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Client Services Director – Medical Education Agency – North West...: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director, Medical Education: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Associate Director: £75, 000-90, 000

Account Director – Healthcare Marketing – Berks: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Subscribe to our email news alerts

PMHub

Add my company

M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....